2022 annual financial data
Rigel Pharmaceuticals 2022 Operating margin
Rigel Pharmaceuticals 2022 operating margin with verified reported values.
Direct answer
Operating margin was -46.2%.
Operating income was -55,550,000 USD and net income was -58,573,000 USD.
Operating cash flow was -73,758,000 USD.
Get free Rigel Pharmaceuticals email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 120,242,000 USD
- Operating income
- -55,550,000 USD
- Net income
- -58,573,000 USD
- Operating cash flow
- -73,758,000 USD